Pharmafile Logo
Pharmafocus logo
Advanced Search

Arthritis drug tocilizumab cuts COVID-19 deaths in hospital trial

February 12, 2021
Medical Communications COVID-19

The rheumatoid arthritis drug tocilizumab can reduce the risk of death in severe COVID-19 patients and shorten the time spent …

News
gilead-sciences

Galapagos and Gilead halt Phase III trials for idiopathic pulmonary fibrosis drug

February 11, 2021
Gilead

Galapagos and Gilead have halted the ISABELA Phase III clinical studies for their autotaxin inhibitor ziritaxestat in patients with idiopathic …

News

NICE recommends treatments for pregnancy sickness in new draft guidance

February 11, 2021
NICE, Pregnant

NICE has recommended treatment options for severe pregnancy sickness for the first time, issuing recommendations in draft guidance published today.

News

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

February 11, 2021
Rentschler

The Cell and Gene Therapy Catapult (CGT Catapult) and Rentschler Biopharma have announced that Rentschler will establish their manufacturing capability …

News
lilly_entrance_web

FDA grants emergency authorisation to Lilly’s COVID-19 antibody combination

February 11, 2021
COVID-19, Eli Lilly

The FDA has granted emergency use authorisation for Eli Lilly’s antibodies bamlanivimab (LY-CoV555) 700mg and etesevimab (LY-CoV016) 1400mg, to be …

News
who_flag

WHO panel recommends AstraZeneca COVID-19 vaccine for over-65s

February 11, 2021
AstraZeneca, COVID-19, WHO

Scientists advising the WHO have recommended the use of the Oxford-AstraZeneca COVID-19 vaccine in all adults, including those aged over …

News
elizabeth_crain

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

February 10, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.

Appointment

Accure Therapeutics’ drug candidate can slow epilepsy progression, study shows

February 10, 2021
Research and Development epilepsy

Accure Therapeutics, an R&D pharmaceutical company in the central nervous system (CNS) field, has announced the publication of a pivotal …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

February 10, 2021
Research and Development COVID-19

The past week has seen lots of positive COVID-19 vaccine news; Oxford University and AstraZeneca have announced development of another …

News
astrazeneca_sign_sky

South Korea approves AstraZeneca COVID-19 vaccine for use

February 10, 2021
Research and Development AstraZeneca, COVID-19

South Korea is to grant first approval for the Oxford University-AstraZeneca vaccine later today, with the rollout expected to start …

News
fdaoutsideweb

FDA approves Sanofi’s Libtayo for advanced basal cell carcinoma

February 10, 2021
Research and Development Cancer, FDA, Sanofi

The FDA has approved Sanofi’s PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the first immunotherapy indicated for patients with advanced basal cell …

News
janssen_latest_logo_on_sign

Janssen announces positive Phase III results for prostate cancer drug apalutamide

February 10, 2021
Research and Development Cancer, Janssen

Final results from Janssen’s Phase III TITAN study have shown its cancer drug apalutamide improved overall survival (OS) in patients …

News
takeda_usa_pharmaceuticals_u

Takeda’s breast cancer treatment approved in Scotland

February 9, 2021
Manufacturing and Production Takeda, breast cancer

The Scottish Medicines Consortium has accepted Takeda’s PROSTAP 3 DCS (leuprorelin acetate) treatment for use in patients with early and …

News
who_flag

WHO backs AstraZeneca vaccine against South African variant

February 9, 2021
Manufacturing and Production COVID-19, WHO, vaccines

World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …

News
abbvie_0

AbbVie’s rheumatoid arthritis drug Rinvoq approved for NHS Scotland

February 9, 2021
Manufacturing and Production AbbVie, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) has recommended AbbVie’s rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for use on the NHS in …

News
landing-hero-images1

ViiV’s HIV drug Rukobia gets EC marketing authorisation

February 9, 2021
Manufacturing and Production HIV, ViiV

The European Commission (EC) has authorised ViiV Healthcare’s Rukobia (fostemsavir) 600mg extended-release tablets for use in combination with other antiretroviral …

News
spravato

Janssen’s esketamine nasal spray gets Europe approval for new indication

February 9, 2021
Manufacturing and Production Europe, Janssen

The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered with oral antidepressant therapy in …

News
mr058666-web

Merck, Pfizer, and 4D pharma join forces for bladder cancer clinical trial

February 8, 2021
Sales and Marketing Cancer, Merck, Pfizer

A clinical trial collaboration between 4D pharma, Merck, and Pfizer to treat locally advanced or metastatic urothelial carcinoma (UC), also …

News

Researchers make neuroblastoma drug target discovery

February 8, 2021
Sales and Marketing Cancer, GOSH, neuroblastoma

Scientists conducting the largest single cell study to date of the childhood cancer neuroblastoma have made a breakthrough in identifying …

News
uk_gov

CureVac enters collaboration with UK government on coronavirus variant vaccines

February 8, 2021
Sales and Marketing COVID-19, CureVac

CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026